| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:08:06 -0700 |
| HMDB ID |
HMDB00223 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Oxalacetic acid |
| Description |
Oxaloacetic acid, also known as oxosuccinic acid or oxalacetic acid, is a four-carbon dicarboxylic acid appearing as an intermediate of the citric acid cycle. In vivo, oxaloacetate (the ionized form of oxaloacetic acid) is formed by the oxidation of L-malate, catalyzed by malate dehydrogenase, and reacts with Acetyl-CoA to form citrate, catalyzed by citrate synthase.(wikipedia) A class of ketodicarboxylic acids derived from oxalic acid. Oxaloacetic acid is an intermediate in the citric acid cycle and is converted to aspartic acidD by a transamination reaction. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 2-Ketosuccinate
- 2-Ketosuccinic acid
- 2-Oxobutanedioate
- 2-Oxobutanedioic acid
- 2-Oxosuccinate
- 2-Oxosuccinic acid
- a-Ketosuccinate
- a-Ketosuccinic acid
- alpha-Ketosuccinate
- alpha-Ketosuccinic acid
- Ketosuccinate
- Ketosuccinic acid
- OAA
- Oxalacetate
- Oxaloacetate
- Oxaloacetic acid
- Oxaloethanoate
- Oxaloethanoic acid
- Oxosuccinate
- Oxosuccinic acid
|
| Chemical Formula |
C4H4O5 |
| Average Molecular Weight |
132.0716 |
| Monoisotopic Molecular Weight |
132.005873238 |
| IUPAC Name |
2-oxobutanedioic acid |
| Traditional IUPAC Name |
oxaloacetic acid |
| CAS Registry Number |
328-42-7 |
| SMILES |
OC(=O)CC(=O)C(O)=O |
| InChI Identifier |
InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9) |
| InChI Key |
KHPXUQMNIQBQEV-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Organic Acids and Derivatives |
| Class |
Carboxylic Acids and Derivatives |
| Sub Class |
Dicarboxylic Acids and Derivatives |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Alpha Keto-Acids and Derivatives
- Beta Keto-Acids and Derivatives
- Dicarboxylic acids(Lipidmaps)
- Fatty Acids and Conjugates
- Short-chain Keto Acids and Derivatives
- oxo dicarboxylic acid(ChEBI)
|
| Substituents |
|
| Direct Parent |
Dicarboxylic Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Alanine and aspartate metabolism
- Component of Arginine and proline metabolism
- Component of Cysteine metabolism
- Component of Glutamate metabolism
- Component of Glyoxylate and dicarboxylate metabolism
- Component of Novobiocin biosynthesis
- Component of Phenylalanine metabolism
- Component of Phenylalanine, tyrosine and tryptophan biosynthesis
- Component of Pyruvate metabolism
- Component of Tyrosine metabolism
|
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
161 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
134 mg/mL |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Cellular Cytoplasm
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Cellular Cytoplasm |
Detected and Quantified |
|
61 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
7.3 (6.1-8.3) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
27 +/- 15 uM |
Not Specified |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.2 (1.16-5.94) umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
After green tea sonsumption
|
| Urine |
Detected and not Quantified |
|
Not Applicable |
Adult (>18 years old) |
Male |
Normal |
After black tea sonsumption
|
| Urine |
Detected and Quantified |
|
2.27 (0.51-4.48) umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Cellular Cytoplasm |
Detected and Quantified |
|
2 uM |
Adult (>18 years old) |
Both |
Anoxia |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Anoxia |
- Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.
Pubmed: 8579834
|
|
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB001479 |
| KNApSAcK ID |
C00001197  |
| Chemspider ID |
945  |
| KEGG Compound ID |
C00036  |
| BioCyc ID |
OXALACETIC_ACID  |
| BiGG ID |
33604  |
| Wikipedia Link |
Oxalacetic acid  |
| NuGOwiki Link |
HMDB00223  |
| Metagene Link |
HMDB00223  |
| METLIN ID |
123  |
| PubChem Compound |
970  |
| PDB ID |
Not Available |
| ChEBI ID |
30744  |
| References |
| Synthesis Reference |
Heidelberger, Charles; Hurlbert, Robert B. The synthesis of oxalacetic acid-I-C14 and orotic acid-6-C14. Journal of the American Chemical Society (1950), 72 4704-6. |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Efimov AS, Gulyi MF, Shcherbak AV, Dzvonkevich ND: [Levels of Krebs cycle metabolites in the blood and urine of patients with diabetes mellitus] Probl Endokrinol (Mosk). 1983 Mar-Apr;29(2):10-4.
Pubmed: 6856592
- el-Sharabasy MM: Observations on calcium oxalate stone formers. Br J Urol. 1992 Nov;70(5):474-7.
Pubmed: 1361403
- Dworzak E, Grunicke H, Berger H, Jarosch E, Haas H, Hopfel I: [Pyruvate dehydrogenase deficiency in a child with persistent lactic acidosis] J Clin Chem Clin Biochem. 1985 Jun;23(6):323-9.
Pubmed: 3926941
- Koike K, Koike M: Fluorescent analysis of alpha-keto acids in serum and urine by high-performance liquid chromatography. Anal Biochem. 1984 Sep;141(2):481-7.
Pubmed: 6437276
- Zupke C, Sinskey AJ, Stephanopoulos G: Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl Microbiol Biotechnol. 1995 Dec;44(1-2):27-36.
Pubmed: 8579834
- Esenmo E, Chandramouli V, Schumann WC, Kumaran K, Wahren J, Landau BR: Use of 14CO2 in estimating rates of hepatic gluconeogenesis. Am J Physiol. 1992 Jul;263(1 Pt 1):E36-41.
Pubmed: 1322046
- Petrarulo M, Facchini P, Cerelli E, Marangella M, Linari F: Citrate in urine determined with a new citrate lyase method. Clin Chem. 1995 Oct;41(10):1518-21.
Pubmed: 7586527
- Sperl W, Maurer H, Dworschak E, Hopfel I, Hammerer I: [Lactic acid acidosis with mitochondrial myopathy due to a pyruvate dehydrogenase deficiency] Padiatr Padol. 1985;20(1):55-67.
Pubmed: 3919358
- Olubuyide IO, Festing MF, Chapman C, Higginson J, Whicher JT: Discriminant analysis of biochemical parameters in liver disease. Trop Gastroenterol. 1997 Jan-Mar;18(1):15-9.
Pubmed: 9197166
- Rabinovich PD, Miliushkin PV: [Content of biological oxidation metabolites in the blood and urine of peptic ulcer patients] Vopr Med Khim. 1979 Nov-Dec;25(6):755-8.
Pubmed: 516538
- Schauenstein E, Kronberger L, Schaur RJ, Fink E, Georgiopulos E: [Malate and oxaloacetate levels in whole blood of patients with and without malignant tumor diseases] Wien Klin Wochenschr. 1973 Jun 29;85(26):478-82.
Pubmed: 4717666
- Sweatman BC, Farrant RD, Holmes E, Ghauri FY, Nicholson JK, Lindon JC: 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal. 1993 Aug;11(8):651-64.
Pubmed: 8257730
- Allen RH, Stabler SP, Savage DG, Lindenbaum J: Elevation of 2-methylcitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism. 1993 Aug;42(8):978-88.
Pubmed: 8345822
- Wong LT, Davidson AG, Applegarth DA, Dimmick JE, Norman MG, Toone JR, Pirie G, Wong J: Biochemical and histologic pathology in an infant with cross-reacting material (negative) pyruvate carboxylase deficiency. Pediatr Res. 1986 Mar;20(3):274-9.
Pubmed: 3085060
|
| Enzymes |
| Name: |
ATP-citrate synthase
|
| Reactions: |
- ADP + phosphate + acetyl-CoA + oxaloacetate = ATP + citrate + CoA [RN:R00352]
|
| Gene Name: |
ACLY |
| Uniprot ID: |
P53396  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
| Name: |
D-aspartate oxidase
|
| Reactions: |
- D-aspartate + H2O + O2 = oxaloacetate + NH3 + H2O2 [RN:R00359]
|
| Gene Name: |
DDO |
| Uniprot ID: |
Q99489  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|